Page last updated: 2024-09-02

1-hydroxymethylmidazolam and 6 beta-hydroxycortisol

1-hydroxymethylmidazolam has been researched along with 6 beta-hydroxycortisol in 4 studies

Compound Research Comparison

Studies
(1-hydroxymethylmidazolam)
Trials
(1-hydroxymethylmidazolam)
Recent Studies (post-2010)
(1-hydroxymethylmidazolam)
Studies
(6 beta-hydroxycortisol)
Trials
(6 beta-hydroxycortisol)
Recent Studies (post-2010) (6 beta-hydroxycortisol)
16346492866551

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Belas, F; Chaudhary, AK; Cvetkovic, M; Dempsey, PJ; Fromm, MF; Kim, RB; Leake, B; Roden, DM; Roden, MM; Wandel, C; Wilkinson, GR; Wood, AJ1
Cheng, ZN; Hu, ZY; Wu, D; Zhao, YS1
Cheng, ZN; Hu, ZY; Li, XM; Luo, X1
Berger, B; Dingemanse, J; Kaufmann, P; Koch, A1

Trials

2 trial(s) available for 1-hydroxymethylmidazolam and 6 beta-hydroxycortisol

ArticleYear
Evaluation of CYP3A activity in humans using three different parameters based on endogenous cortisol metabolism.
    Acta pharmacologica Sinica, 2009, Volume: 30, Issue:9

    Topics: Clarithromycin; Cross-Over Studies; Cytochrome P-450 CYP3A; Female; Humans; Hydrocortisone; Male; Midazolam; Young Adult

2009
Impact of the Selective Orexin-1 Receptor Antagonist ACT-539313 on the Pharmacokinetics of the CYP3A Probe Drug Midazolam in Healthy Male Subjects.
    Journal of clinical pharmacology, 2020, Volume: 60, Issue:7

    Topics: Adult; Area Under Curve; Biomarkers; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Administration Schedule; Drug Interactions; Healthy Volunteers; Humans; Hydrocortisone; Male; Midazolam; Middle Aged; Orexin Receptor Antagonists; Orexin Receptors; Young Adult

2020

Other Studies

2 other study(ies) available for 1-hydroxymethylmidazolam and 6 beta-hydroxycortisol

ArticleYear
Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.
    Pharmaceutical research, 1999, Volume: 16, Issue:3

    Topics: Animals; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Caco-2 Cells; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple; Enzyme Inhibitors; Humans; Male; Mice; Oxidoreductases, N-Demethylating; Pharmacokinetics; Substrate Specificity

1999
Endogenous cortisol 6 beta-hydroxylation clearance is not an accurate probe for overall cytochrome P450 3A phenotyping in humans.
    Clinica chimica acta; international journal of clinical chemistry, 2009, Volume: 408, Issue:1-2

    Topics: Administration, Oral; Cytochrome P-450 CYP3A; Female; Humans; Hydrocortisone; Hydroxylation; Male; Midazolam; Phenotype; Time Factors

2009